![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-07/FrontLineHead.Blanke.2022-web-sized_1.png?itok=7NROqQaI)
Jul 14, 2023
Monitoring disease with serum tumor markers vs. imaging
![Lung-MAP: A lung cancer precision medicine trial](/sites/default/files/styles/news_recent/public/news/2023-07/LungMap.Twitter%201.png?itok=myIZC7dP)
Jul 5, 2023
The summer 2023 issue of the Lung-MAP Newsletter is now available!
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-06/FrontLineHead.Blanke.2022-web-sized_3.png?itok=GB-Sq0yK)
Jun 30, 2023
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-06/FrontLineHead.Blanke.2022-web-sized_2.png?itok=Vvl5a6vH)
Jun 23, 2023
![Best of SWOG: June 28, 2023](/sites/default/files/styles/news_recent/public/news/2023-06/BOS.FINAL_.20230609..png?itok=VXMF7UqL)
Jun 14, 2023
![S1826 at ASCO 2023 Plenary Session](/sites/default/files/styles/news_recent/public/news/2023-06/press-card-S1826-Herrera-small.png?itok=lF8NLiCh)
Jun 4, 2023
Nivolumab added to AVD chemotherapy expected to become new standard for initial treatment for advanced stage disease in adolescents and adults, based on trial data to be presented at 2023 ASCO Annual Meeting plenary session